Premium
Fucoidan Prevents High‐Fat Diet‐Induced Obesity in Animals by Suppression of Fat Accumulation
Author(s) -
Kim MiJa,
Jeon Joseph,
Lee JinSil
Publication year - 2014
Publication title -
phytotherapy research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.019
H-Index - 129
eISSN - 1099-1573
pISSN - 0951-418X
DOI - 10.1002/ptr.4965
Subject(s) - fucoidan , obesity , fat accumulation , medicine , endocrinology , biology , food science , polysaccharide , biochemistry
This study examines the antiobesity effects of fucoidan in an animal model of diet‐induced obesity. Mice were fed a standard diet or high‐fat diet (HFD) for 5 weeks. After that, the mice were divided into four experimental groups, with 10 mice per group, including a standard diet group, HFD group, HFD containing 1% fucoidan (HFD + FUCO 1%) group and HFD containing 2% fucoidan (HFD + FUCO 2%) group. The fucoidan supplementation group had significantly decreased body‐weight gain, food efficiency ratio and relative liver and epididymal fat mass compared with the HFD group. The mice supplemented with fucoidan showed significantly reduced triglyceride, total cholesterol and low‐density lipoprotein levels in the plasma. Liver steatosis induced by the HFD improved in the fucoidan‐supplemented group. Furthermore, fucoidan affected the down‐regulation expression patterns of epididymal adipose tissue genes such as peroxisome proliferator‐activated receptor γ, adipose‐specific fatty acid binding protein and acetyl CoA carboxylase. Therefore, fucoidan may be considered for use in improving obesity. Copyright © 2013 John Wiley & Sons, Ltd.